Hirotoshi Akita-Dosaka
Sapporo, 0608648, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Author's reply to "Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer".
Journal: Japanese journal of clinical oncology
Published: August 07, 2025
Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer.
Journal: Japanese journal of clinical oncology
Published: April 27, 2025
Non-small cell lung cancer with synchronous brain metastases: Identification of prognostic factors in a retrospective multicenter study (HOT 1701).
Journal: Neuro-oncology advances
Published: November 14, 2024
Polymorphisms of the PD-L1 gene 3'-untranslated region are associated with the expression of PD-L1 in non-small cell lung cancer.
Journal: Genes, chromosomes & cancer
Published: February 14, 2023
Real-world data on the efficacy and safety of immune-checkpoint inhibitors in elderly patients with non-small cell lung cancer.
Journal: Cancer medicine
Published: January 15, 2023
Association between skin immune-related adverse events (irAEs) and multisystem irAEs during PD-1/PD-L1 inhibitor monotherapy.
Journal: Journal of cancer research and clinical oncology
Published: August 19, 2022
Risk Factor Analysis for the Occurrence of Severe Adverse Effects in Eribulin Treatment.
Journal: Anticancer research
Published: May 24, 2022
Last Updated: 09/26/2026